Clinical Trial Update: Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the pharmacokinetics and safety of BAY3427080 (NT-814) in postmenopausal women with vasomotor symptoms; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms

Drugs mentioned

• BAY3427080 (NT-814) (NT-814)

Snippet

Sponsor: Bayer | Conditions: Post-menopausal Vasomotor Symptoms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-16